Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Myasthenia Gravis × 90 days × Clear all

Phase

Status

Sponsor Class

INDUSTRY 49 OTHER 16 NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 18 Prostatic Neoplasms 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Neoplasms 12 Carcinoma, Non-Small-Cell Lung 11 Leukemia, Myeloid, Acute 9 Melanoma 8 Lymphoma, Non-Hodgkin 8 Lymphoma 8 Multiple Myeloma 7 Neuroblastoma 6 Squamous Cell Carcinoma of Head and Neck 5 Leukemia, Biphenotypic, Acute 5 Hematologic Neoplasms 5 Glioblastoma 5 Colorectal Neoplasms 5 Myelodysplastic Syndromes 4 Medulloblastoma 4 Lung Neoplasms 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Leukemia 4 HIV Infections 4 Glioma 4 Ganglioneuroblastoma 4 Ependymoma 4 Astrocytoma 4 Sarcoma, Kaposi 3 Sarcoma, Ewing 3 Recurrence 3 Rectal Neoplasms 3

Interventions

Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06342544 2026-01-21

IMCOMG

Fondation Ophtalmologique Adolphe de Rothschild

Phase 3 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡